Search

everythinglearnresearchcommunity

for

Search:↓

Orlistat helped reduce weight and testosterone in obese women with PCOS but did not significantly affect other androgens or cholesterol levels.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

New treatments for PCOS using smart drug delivery, metabolic changes, and AI show promise but need more research.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

A girl with lupus and trisomy X has a higher risk of bone problems like avascular necrosis and osteoporosis.

Drinking sweetened tea and poor sleep habits may increase the risk of hair loss in women.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Reducing iron levels didn't improve heart health or metabolism in women with certain ovarian issues.

STK11 gene polymorphism does not predict metformin response in PCOS.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Polycystic ovary syndrome is a common hormonal disorder in women, linked to increased risk of metabolic and heart diseases, and needs more research for better understanding and treatment.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Older age, obesity, hirsutism, and having children increase metabolic risk in women with PCOS.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

Resveratrol improved hormone levels, menstrual cycles, hair loss, and ovarian function in PCOS patients.

Genes and epigenetic changes are important in the development of Polycystic Ovary Syndrome.

Losing weight, possibly through bariatric surgery, is key to improving PCOS and hyperandrogenism symptoms in obese patients.

Idiopathic hirsutism is the most common cause of hirsutism in women, followed by PCOS.

PCOS treatment should be personalized, using birth control pills or metformin for symptoms, with lifestyle changes being essential.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

Different treatments for PCOS focus on the specific symptoms, with weight loss and lifestyle changes being important.

Surgery can be a safe and effective option for infertile women with PCOS who don't respond to medication and want to get pregnant.

The document concludes that the fast-growing direct-to-consumer genetic testing market lacks sufficient regulation, posing risks to consumers due to questionable test quality and accuracy.

PCOS is linked to inflammation, and certain markers could help in its treatment.

Sex hormones likely don't affect atopic dermatitis in adolescents and adults.

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

PCOS management involves medication, lifestyle changes, and personalized treatment to address symptoms and improve health.